Charles Schwab’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-894,104
| Closed | -$16.1M | – | 3623 |
|
|
2025
Q1 | $16.1M | Sell |
894,104
-97,899
| -10% | -$1.74M | ﹤0.01% | 1742 |
|
|
2024
Q4 | $17.3M | Buy |
992,003
+9,342
| +1% | +$126K | ﹤0.01% | 1773 |
|
|
2024
Q3 | $11.3M | Buy |
982,661
+16,029
| +2% | +$184K | ﹤0.01% | 1974 |
|
|
2024
Q2 | $10.9M | Sell |
966,632
-50,862
| -5% | -$677K | ﹤0.01% | 2000 |
|
|
2024
Q1 | $14.6M | Buy |
1,017,494
+29,366
| +3% | +$416K | ﹤0.01% | 1792 |
|
|
2023
Q4 | $13.5M | Buy |
988,128
+24,018
| +2% | +$253K | ﹤0.01% | 1836 |
|
|
2023
Q3 | $7.84M | Buy |
964,110
+77,129
| +9% | +$630K | ﹤0.01% | 2045 |
|
|
2023
Q2 | $6.71M | Buy |
886,981
+32,190
| +4% | +$246K | ﹤0.01% | 2096 |
|
|
2023
Q1 | $6.84M | Buy |
854,791
+5,884
| +0.7% | +$60.5K | ﹤0.01% | 2060 |
|
|
2022
Q4 | $9.64M | Buy |
848,907
+128,363
| +18% | +$1.4M | ﹤0.01% | 1878 |
|
|
2022
Q3 | $6.29M | Buy |
720,544
+129,930
| +22% | +$1.35M | ﹤0.01% | 2100 |
|
|
2022
Q2 | $5.88M | Buy |
590,614
+156,703
| +36% | +$1.58M | ﹤0.01% | 2120 |
|
|
2022
Q1 | $4.37M | Buy |
433,911
+133,133
| +44% | +$1.42M | ﹤0.01% | 2336 |
|
|
2021
Q4 | $3.81M | Buy |
300,778
+6,668
| +2% | +$86.8K | ﹤0.01% | 2479 |
|
|
2021
Q3 | $3.68M | Buy |
294,110
+6,244
| +2% | +$84.7K | ﹤0.01% | 2516 |
|
|
2021
Q2 | $4.34M | Buy |
287,866
+14,831
| +5% | +$223K | ﹤0.01% | 2419 |
|
|
2021
Q1 | $3.75M | Buy |
273,035
+7,316
| +3% | +$113K | ﹤0.01% | 2434 |
|
|
2020
Q4 | $4.82M | Buy |
+265,719
| New | +$4.1M | ﹤0.01% | 2239 |
|
Charles Schwab's PTVE Position: Q2 2025 in Review
Charles Schwab sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 894,104 shares — an estimated $16.1M sold.
Charles Schwab first reported a position in PTVE in Q4 2020 and held it in 18 quarters. The position peaked at $17.3M in Q4 2024. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- Charles Schwab reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- Charles Schwab sold 894,104 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $16.1M.
- Charles Schwab first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2020 and held it in 18 quarters.
- Charles Schwab's Pactiv Evergreen Inc. Common stock position peaked at $17.3M in Q4 2024.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.